Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update
Shares of Aurinia Pharmaceuticals saw a handy gain on Wednesday after the company gave an update on its lupus nephritis treatment.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 186
AnaptysBio Files for IPO
AnaptysBio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Trump Corporate Tax Cuts Could Really Help These 4 Large Cap Companies
A new research report from JPMorgan makes the case that lowering the corporate tax rate could be huge for many large cap companies, including in the medical technology industry.
Synthetic Biologics Prices Secondary Offering
Synthetic Biologics has announced the pricing for its secondary offering and expects to make $25 million from the offering.
BeyondSpring Gears Up for IPO
BeyondSpring has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Why Teva Sank Despite Solid Earnings and Guidance
Teva Pharmaceutical Industries released a mixed third-quarter earnings reports before the markets opened on Tuesday.
What to Look for in Teva Pharmaceuticals Earnings
Teva Pharmaceuticals has so far been unable to escape its rough patch in 2016. However there may now be a light at the end of the tunnel, considering the election results.
Why Dynavax Shares Are in Freefall
Dynavax Technologies Corp. (NASDAQ: DVAX) shares  crumbled Monday morning after the company said that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). Specifically the CRL is in…
Corbus Pharmaceuticals Skyrockets on Positive Mid-Stage Results
Corbus Pharmaceuticals shares skyrocketed on Monday morning after the company announced positive results from its mid-stage clinical trial in systemic sclerosis.
Motif Bio Closes in on IPO
Motif Bio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep
With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there could be far less scrutiny on drug pricing.
Why PTC Therapeutics Is Soaring
PTC Therapeutics shares skyrocketed early on Friday after the company received positive news from the European Medicines Agency.
Gilead Scores Another Hepatitis FDA Approval
Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.
Anthera Pharmaceuticals Slides on Missed Late Stage Results
Shares of Anthera Pharmaceuticals lost roughly one-third of their value on Thursday after the company gave an update on its late-stage Lupus clinical trial.
Short Interest Bets Increase on Major Pharma
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.